Company intelligence / Profile preview
Hebei Taihe Chunyu Biotechnology
Hebei Sheng, Chinaadisinsight.springer.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Hebei Taihe Chunyu Biotechnology is a private Chinese biotech company developing next-generation CAR-T cell therapies targeting hematologic malignancies. Its lead assets include a CD7-specific CAR-T, a nanobody-based biepitope BCMA-targeting CAR-T, and bispecific CD19&CD20-targeted CAR-T cells. Early clinical results in relapsed/refractory patients with multiple myeloma and B-cell leukemia/lymphoma show promising safety and efficacy, including high response rates and manageable toxicity profiles when combined with pomalidomide. All programs are currently in Phase 1/2 trials.
- Therapeutic areas
- HematologyOncology
- Modalities
- CAR-T cell therapyNanobody-based CAR-T cell therapy
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Wuhan Xiehe Hospital Tower / Wuhan Union Hospital
Beyond the preview
Go deeper on Hebei Taihe Chunyu Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hebei Taihe Chunyu Biotechnology.